Vaccines for Neglected Pathogens: Strategies, Achievements and Challenges
portes grátis
Vaccines for Neglected Pathogens: Strategies, Achievements and Challenges
Focus on Leprosy, Leishmaniasis, Melioidosis and Tuberculosis
Christodoulides, Myron
Springer International Publishing AG
03/2023
344
Dura
Inglês
9783031243547
15 a 20 dias
Descrição não disponível.
Preface by Prof Myron Christodoulides, University of Southampton, UK.-1. Introduction chapter on the VALIDATE network.- (Prof Helen McShane, Director Oxford NIHR Biomedical Research Centre, University of Oxford, UK and Samantha Vermaak, The Jenner Institute Laboratories, Oxford, UK).- Part I: Leprosy.- 2. Leprosy challenges to vaccine developers.- (Dr Hua Wang, University of Glasgow, UK).- 3. Leprosy vaccine development.- (Dr Khushboo Borah, University of Surrey, UK).- Part II: Tuberculosis.- 4. Biomarkers in tuberculosis vaccine development.- (Dr Kenneth Akwue, University of the Witwatersrand, Johannesburg, South Africa).- 5. Tuberculosis correlates of protection (Dr Rachel Tanner, The Jenner Institute Laboratories, Oxford, UK),.- Animal models for tuberculosis(Dr. Hao Li, China Agricultural University, Beijing, China).- 7. BCG vaccination .- (Dr Hazel Morrison, The Jenner Institute Laboratories, Oxford, UK).- 8. Vaccination strategies for Buruli ulcer disease (Dr Rachel Simmonds, University of Surrey, UK).- 9. Fermentation in vaccine development (BCG)(Dr. Joanna Bacon, Public Health England, UK Government, London, UK).- Part III: Leishmaniasis:10. Human leishmaniasis vaccination.- (Dr Ali Bordbar, Institute Pasteur of Iran, Tehran, Iran).- 11. Aspects of human leishmaniasis vaccine use.- (Dr Olayinka Osuolale, Elizade University, Ilara-Mokin, Nigeria).- 12. Human challenge model for developing leishmaniasis vaccines (Prof Paul Kaye, University of York, UK).- 13. Canine leishmaniasis vaccines.- (Prof Eduardo Coelho, Federal University of Minas Gerais, Belo Horizonte, Brazil and Prof Myron Christodoulides, University of Southampton, UK).- Part IV: Melioidosis.- 14. Vaccines for melioidosis (Prof Chiranjay Mukhopadhyay, Kasturba Medical College, Manipal, India).- 15. West Africa burden of disease (Dr Tukur Ismail, Zamfara State Primary Healthcare Board, Gusau, Nigeria)
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
leishmaniasis;neglected tropical disease;Tuberculosis;biomarkers;Leprosy;melioidosis;Buruli ulcer disease;infectious disease treatment;vaccine development;Open Access
Preface by Prof Myron Christodoulides, University of Southampton, UK.-1. Introduction chapter on the VALIDATE network.- (Prof Helen McShane, Director Oxford NIHR Biomedical Research Centre, University of Oxford, UK and Samantha Vermaak, The Jenner Institute Laboratories, Oxford, UK).- Part I: Leprosy.- 2. Leprosy challenges to vaccine developers.- (Dr Hua Wang, University of Glasgow, UK).- 3. Leprosy vaccine development.- (Dr Khushboo Borah, University of Surrey, UK).- Part II: Tuberculosis.- 4. Biomarkers in tuberculosis vaccine development.- (Dr Kenneth Akwue, University of the Witwatersrand, Johannesburg, South Africa).- 5. Tuberculosis correlates of protection (Dr Rachel Tanner, The Jenner Institute Laboratories, Oxford, UK),.- Animal models for tuberculosis(Dr. Hao Li, China Agricultural University, Beijing, China).- 7. BCG vaccination .- (Dr Hazel Morrison, The Jenner Institute Laboratories, Oxford, UK).- 8. Vaccination strategies for Buruli ulcer disease (Dr Rachel Simmonds, University of Surrey, UK).- 9. Fermentation in vaccine development (BCG)(Dr. Joanna Bacon, Public Health England, UK Government, London, UK).- Part III: Leishmaniasis:10. Human leishmaniasis vaccination.- (Dr Ali Bordbar, Institute Pasteur of Iran, Tehran, Iran).- 11. Aspects of human leishmaniasis vaccine use.- (Dr Olayinka Osuolale, Elizade University, Ilara-Mokin, Nigeria).- 12. Human challenge model for developing leishmaniasis vaccines (Prof Paul Kaye, University of York, UK).- 13. Canine leishmaniasis vaccines.- (Prof Eduardo Coelho, Federal University of Minas Gerais, Belo Horizonte, Brazil and Prof Myron Christodoulides, University of Southampton, UK).- Part IV: Melioidosis.- 14. Vaccines for melioidosis (Prof Chiranjay Mukhopadhyay, Kasturba Medical College, Manipal, India).- 15. West Africa burden of disease (Dr Tukur Ismail, Zamfara State Primary Healthcare Board, Gusau, Nigeria)
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
